⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Investors Urged to Contact Levi & Korsinsky for Information Before September 14, 2026 - Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. (REGN) Investors - Lead Plaintiff Deadline on September 14, 2026
accessnewswire.com
REGN
Class Action Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - Recover Losses - Contact Levi & Korsinsky Before September 14, 2026
accessnewswire.com
REGN
Securities Lawsuit Alert: Regeneron Pharmaceuticals, Inc. (REGN) – Contact Levi & Korsinsky Before September 14, 2026
accessnewswire.com
REGN
Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress
globenewswire.com
TLX
REGN
Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Contact Levi & Korsinsky to Join Class Action Before September 14, 2026
accessnewswire.com
REGN
REGN EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 Ready to Announce with Confidence?
newsfilecorp.com
REGN
REGENERNON PHARMACEUTICALS, INC. (REGN) INVESTOR ALERT Investors With Large Losses in Regeneron Pharmaceuticals, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
globenewswire.com
REGN
REGN Shareholder Alert: September 14, 2026 Lead Plaintiff Deadline in Regeneron Pharmaceuticals Securities Class Action – Contact Levi & Korsinsky
globenewswire.com
REGN
Recover Investment Losses: Class Action Initiated Against Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN